Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
- PMID: 35667744
- PMCID: PMC8743385
- DOI: 10.1016/j.ccc.2022.01.005
Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
Abstract
Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approximately 3 to 6 weeks mostly after an asymptomatic or mild SARS-CoV-2 infection. For both types of complications, supportive ICU care is often required. For MIS-C critical illness, immunomodulation is prescribed to reverse hyperinflammation and its cardiac and other sequelae.
Keywords: COVID-19; MIS-C; Multisystem inflammatory syndrome; Pediatrics.
Copyright © 2022 Elsevier Inc. All rights reserved.
Figures
References
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
